logo

Agile Therapeutics Inc. (AGRX)



Trade AGRX now with
  Date
  Headline
8/11/2020 4:05:26 PM Agile Therapeutics Q2 Loss/share $0.12 Vs. Loss $0.08 Year Ago
3/13/2019 9:13:35 AM William Blair Is Raising Agile Therapeutics Inc. (AGRX) FY19 Estimate To -0.34 From -0.42
9/14/2017 7:10:23 AM RBC Capital Markets Is Increasing Agile Therapeutics Inc. (AGRX) 4Q18 Estimate To -0.23 From -0.28
9/14/2017 7:10:08 AM RBC Capital Markets Is Increasing Agile Therapeutics Inc. (AGRX) 3Q18 Estimate To -0.24 From -0.25
9/14/2017 7:09:47 AM RBC Capital Markets Is Cutting Agile Therapeutics Inc. (AGRX) 2019 Rev. Estimate To 92.6 M From 105.8 M
9/14/2017 7:09:33 AM RBC Capital Markets Is Lowering Agile Therapeutics Inc. (AGRX) 2018 Rev. Estimate To 18.8 M From 52.6 M
9/14/2017 7:08:57 AM RBC Capital Markets Is Lowering Agile Therapeutics Inc. (AGRX) 2019 Estimate To 0.52 From 0.82
9/14/2017 7:08:41 AM RBC Capital Markets Is Cutting Agile Therapeutics Inc. (AGRX) 2018 Estimate To -1.02 From -0.40
1/4/2017 6:22:58 AM RBC Capital Markets Is Lowering Agile Therapeutics Inc. (AGRX) 2018 Estimate To -0.40 From 0.21
1/4/2017 6:22:32 AM RBC Capital Markets Is Raising Agile Therapeutics Inc. (AGRX) 2017 Estimate To -1.08 From -1.34
1/4/2017 6:22:01 AM RBC Capital Markets Is Increasing Agile Therapeutics Inc. (AGRX) Q4 17 Estimate To -0.34 From -0.52
1/4/2017 6:21:41 AM RBC Capital Markets Is Increasing Agile Therapeutics Inc. (AGRX) Q3 17 Estimate To -0.26 From -0.34
1/4/2017 6:21:25 AM RBC Capital Markets Is Lowering Agile Therapeutics Inc. (AGRX) Q2 17 Estimate To -0.25 From -0.23
11/8/2016 7:10:13 AM RBC Capital Markets Is Lowering Agile Therapeutics Inc. (AGRX) 2017 Estimate To -1.34 From -1.12